carvedilol has been researched along with gadolinium in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Angielski, S; Dobrucki, LW; Jankowski, M; Kalinowski, L; Malinski, T; Martyniec, L; Szczepanska-Konkel, M | 1 |
Akashi, YJ; Kida, K; Kobayashi, Y; Miyake, F; Takano, M; Yoneyama, K | 1 |
2 other study(ies) available for carvedilol and gadolinium
Article | Year |
---|---|
Third-generation beta-blockers stimulate nitric oxide release from endothelial cells through ATP efflux: a novel mechanism for antihypertensive action.
Topics: Adenosine Triphosphate; Adrenergic beta-Antagonists; Angiotensin II; Animals; Antihypertensive Agents; Benzopyrans; Carbazoles; Carvedilol; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Ethanolamines; Extracellular Space; Gadolinium; Intracellular Fluid; Kidney Glomerulus; Luminescent Measurements; Male; Microcirculation; Nebivolol; Nitric Oxide; Propanolamines; Rats; Receptors, Purinergic P2; Suramin; Vasoconstriction; Vasodilation | 2003 |
Late gadolinium enhancement on cardiac magnetic resonance images predicts reverse remodeling in patients with nonischemic cardiomyopathy treated with carvedilol.
Topics: Adult; Aged; Carbazoles; Cardiomyopathies; Carvedilol; Female; Gadolinium; Heart Failure; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Predictive Value of Tests; Propanolamines; Time Factors; Treatment Outcome; Vasodilator Agents; Ventricular Remodeling | 2013 |